[go: up one dir, main page]

GB202206257D0 - Biomarkers of diabetic nephropathy - Google Patents

Biomarkers of diabetic nephropathy

Info

Publication number
GB202206257D0
GB202206257D0 GBGB2206257.4A GB202206257A GB202206257D0 GB 202206257 D0 GB202206257 D0 GB 202206257D0 GB 202206257 A GB202206257 A GB 202206257A GB 202206257 D0 GB202206257 D0 GB 202206257D0
Authority
GB
United Kingdom
Prior art keywords
biomarkers
diabetic nephropathy
nephropathy
diabetic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB2206257.4A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Randox Laboratories Ltd
Original Assignee
Randox Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Randox Laboratories Ltd filed Critical Randox Laboratories Ltd
Priority to GBGB2206257.4A priority Critical patent/GB202206257D0/en
Publication of GB202206257D0 publication Critical patent/GB202206257D0/en
Priority to EP23723436.4A priority patent/EP4515245A1/en
Priority to PCT/EP2023/060911 priority patent/WO2023208993A1/en
Ceased legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/04Endocrine or metabolic disorders
    • G01N2800/042Disorders of carbohydrate metabolism, e.g. diabetes, glucose metabolism
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/34Genitourinary disorders
    • G01N2800/347Renal failures; Glomerular diseases; Tubulointerstitial diseases, e.g. nephritic syndrome, glomerulonephritis; Renovascular diseases, e.g. renal artery occlusion, nephropathy

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
GBGB2206257.4A 2022-04-29 2022-04-29 Biomarkers of diabetic nephropathy Ceased GB202206257D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GBGB2206257.4A GB202206257D0 (en) 2022-04-29 2022-04-29 Biomarkers of diabetic nephropathy
EP23723436.4A EP4515245A1 (en) 2022-04-29 2023-04-26 Biomarkers of diabetic nephropathy
PCT/EP2023/060911 WO2023208993A1 (en) 2022-04-29 2023-04-26 Biomarkers of diabetic nephropathy

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2206257.4A GB202206257D0 (en) 2022-04-29 2022-04-29 Biomarkers of diabetic nephropathy

Publications (1)

Publication Number Publication Date
GB202206257D0 true GB202206257D0 (en) 2022-06-15

Family

ID=81943882

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2206257.4A Ceased GB202206257D0 (en) 2022-04-29 2022-04-29 Biomarkers of diabetic nephropathy

Country Status (3)

Country Link
EP (1) EP4515245A1 (en)
GB (1) GB202206257D0 (en)
WO (1) WO2023208993A1 (en)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0874242B2 (en) 1997-04-21 2009-06-03 Randox Laboratories Ltd. Device and apparatus for the simultaneous detection of multiple analytes
EP2913676A1 (en) * 2008-11-10 2015-09-02 Astute Medical, Inc. Methods and compositions for diagnosis and prognosis of renal injury and renal failure
DK2406636T3 (en) * 2008-12-10 2019-02-18 Joslin Diabetes Center Inc PROCEDURES FOR DIAGNOSTICATION AND PREVENTION OF RENAL DISEASE
GB201804648D0 (en) * 2018-03-22 2018-05-09 Randox Laboratories Ltd Combination biomarker

Also Published As

Publication number Publication date
WO2023208993A1 (en) 2023-11-02
EP4515245A1 (en) 2025-03-05

Similar Documents

Publication Publication Date Title
EP4093513A4 (en) Uses of biomarkers for improving immunotherapy
PL4070111T3 (en) Use of cell free nucleosomes as biomarkers
GB202206257D0 (en) Biomarkers of diabetic nephropathy
ZA202108391B (en) Biomarkers for predicting progression of intravenous leiomyomatosis
GB202014880D0 (en) Detection of biomarkers
GB202112831D0 (en) Biomarker
GB202014190D0 (en) Biomarkers
EP4083627A4 (en) Prognostic biomarker of cancer
GB202216420D0 (en) Biomarkers of pregnancy loss
GB202103951D0 (en) Biomarkers
GB202107813D0 (en) Biomarker
GB202015056D0 (en) Biomarkers
GB202114694D0 (en) Prediction of fade outages
GB202314954D0 (en) Biomarkers
GB202216295D0 (en) Biomarkers
GB202215749D0 (en) Biomarkers
GB202212826D0 (en) Biomarkers
GB202307768D0 (en) Use of cell free nucleosomes as biomarkers
GB202509310D0 (en) Biomarkers
GB202419126D0 (en) Biomarkers
GB202418087D0 (en) Biomarkers
GB202413914D0 (en) Biomarkers
GB202411373D0 (en) Biomarkers
GB202409296D0 (en) Biomarkers
GB202403274D0 (en) Biomarkers

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)